SUPPORT FROM MEDICAL ORGANIZATIONS Various professional organizations recognize the therapeutic benefits of marijuana and support its rescheduling to facilitate more research and reduce regulatory barriers. This support underscores the medical community's confidence in marijuana's safety and efficacy. REGULATORY AND ECONOMIC BENEFITS Rescheduling marijuana to Schedule III will enable more research and development into its medical uses, potentially leading to new treatments and medications. It will also align with international treaty obligations, ensuring compliance while allowing for domestic regulatory flexibility.
CONCLUSION
Rescheduling marijuana to Schedule III is justified by its lower abuse potential, recognized medical use, and manageable safety profile. This change will benefit patients and support economic growth, especially in minority communities.
I urge the DEA to proceed with rescheduling marijuana to Schedule III.
Thank you for considering my comments
Sincerely,
[Your Name]
Members and advocates can use this letter as a template to submit their comments to the DEA Rules Making public comment site at regulations.gov.
PAGE 14
Made with FlippingBook - professional solution for displaying marketing and sales documents online